Desjardins Global Asset Management’s Bio-Techne TECH Stock Holding History

Desjardins Global Asset Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$37.4K	Buy	485 +4	+0.8%	+$263	﹤0.01%	562
2023 Q3	$32.7K	Sell	481 -2,823	-85%	-$223K	﹤0.01%	572
2023 Q2	$270K	Buy	3,304 +1,199	+57%	+$96.4K	0.03%	394
2023 Q1	$156K	Sell	2,105 -135	-6%	-$10.4K	0.02%	429
2022 Q4	$185K	Buy	2,240 +52	+2%	+$4.13K	0.03%	349
2022 Q3	$155K	Hold	2,188	–	–	0.02%	365
2022 Q2	$189K	Sell	2,188 -1,812	-45%	-$170K	0.02%	351
2022 Q1	$433K	Sell	4,000 -100	-2%	-$10.3K	0.04%	275
2021 Q4	$530K	Buy	+4,100	New	+$503K	0.05%	273

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Desjardins Global Asset Management's TECH Position: Q4 2023 in Review

Desjardins Global Asset Management increased its Bio-Techne (TECH) stake by 0.83% in Q4 2023, buying an estimated $263 and bringing the position to 485 shares worth $37.4K. The position accounts for ﹤0.01% of the portfolio, ranked #562.

Desjardins Global Asset Management first reported a position in TECH in Q4 2021 and has held it in 9 quarters since. The position peaked at $530K in Q4 2021. 530 funds tracked by Wall St. Rank hold TECH as of Q4 2023.

Desjardins Global Asset Management held 485 shares of Bio-Techne worth $37.4K as of Q4 2023.
Desjardins Global Asset Management bought 4 Bio-Techne shares in Q4 2023, an estimated $263.
Bio-Techne made up ﹤0.01% of Desjardins Global Asset Management's portfolio in Q4 2023, its #562 holding.
Desjardins Global Asset Management first reported a position in Bio-Techne in Q4 2021 and has held it in 9 quarters since.
Desjardins Global Asset Management's Bio-Techne position peaked at $530K in Q4 2021.
530 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.